University of Miami Sylvester Comprehensive Cancer Center
Avatar

COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifying Treatment for Cancer Patients

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Gilberto Lopes
April 1, 2020
10 Comments
Login to view comments. Click here to Login

Featured Video

45:38
Novartis Oncology

A Discussion of PIK3CA Mutations in HR+/HER2- Advanced Breast Cancer

Feat. S. Donahue, N. Oncology, H. Rugo

Featured Video

16:20
Lilly

Exploring Statistically Significant Trial Data

Feat. P. A. Kaufman

Related Content

AUTOPLAY
21:42
UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Risk, CO…

Feat. R. Gangaraju
33:24
Zahra Pakbaz

Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, Hemoly…

12:10
Penn Medicine Abramson Cancer Center

2021 Updates in Medical Oncology for Lung Cancer: Targeted Therapy, Tumor …

Feat. C. Aggarwal
10:25
Houston Methodist DeBakey Heart and Vascular Center

COVID-19 & Cytokine Storm: What Kind of Inflammatory Markers Are Released …

Feat. J. Chang
09:15
8th Eurasian Hematology Oncology Summit

How I Treat ET in 2021: WHO True-ET, Thromboembolic/Bleeding Complications…

Feat. D. Wolf
13:34
UAB Hematology Review 2021

CLL Management in Times of COVID-19: Frontline Acalabrutinib or Ven +/- Ob…

Feat. M. Narkhede
15:32
Penn Medicine Abramson Cancer Center

COVID-19 Vaccination Guidelines for Our Cancer Patients: What Are the Elig…

Feat. L. Schuchter
21:47
Total Health Conferencing

Shared Expert Experience on the CML Management in the Time of COVID-19: Ho…

Feat. T. Kadia, F. Santos, H. Malhotra
47:07
Penn Medicine Abramson Cancer Center

Updates on Breast Care and Imaging During COVID-19: Vaccine-Related Axilla…

Feat. R. Jankowitz, E. Conant, T. D'Entremont, A. Steiner, J. Tchou
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm, Impl…

Feat. L. Calabrese
15:18
Memorial Sloan Kettering Cancer Center

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for Che…

Feat. D. Reidy-Lagunes
33:00
Total Health Conferencing

Will COVID-19 Leave Its Mark on Cancer Care?

Feat. G. Lopes
15:40
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 & Hematologic Malignancies: What Is the Mortality Estimate Per Ma…

Feat. J. Leal
17:35
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Coagulopathy: What Is Virchow’s Triad? What Are the VTE Rates in …

Feat. P. Harris
13:17
Penn Medicine Abramson Cancer Center

Penn Updates on RT in Lung Cancer During COVID-19: SBRT vs. Surgery, Antim…

Feat. A. Berman
12:50
Moffitt Cancer Center

Melanoma Drug Therapy During COVID-19: When to Wait or Go Forward With the…

Feat. Z. Eroglu, V. Sondak
15:18
Penn Medicine Abramson Cancer Center

Penn Medicine Melanoma Management During COVID-19: What Are the Main Conce…

Feat. E. Chu, R. Bronfenbrener, C. J. Miller
18:31
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Therapeutics: Remdesivir/Bamlanivimab/Casirivimab+Imdevimab - Wha…

Feat. K. Konrardy
10:01
Moffitt Cancer Center

COVID-19 in Lung Cancer Patients: Does Chemotherapy Increase the Severity …

Feat. M. Shafique
11:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Experience on COVID-19 & Cancer: Disease Biology, Risks of Syste…

Feat. A. Kutikov